A5045294168- RNA modifications and cancer
- Radiomics and Machine Learning in Medical Imaging
- Fungal Biology and Applications
- Cancer Treatment and Pharmacology
- Digital Radiography and Breast Imaging
- Breast Lesions and Carcinomas
- AI in cancer detection
- MRI in cancer diagnosis
- Cancer, Lipids, and Metabolism
- HER2/EGFR in Cancer Research
- Glycosylation and Glycoproteins Research
- Medical Imaging Techniques and Applications
- 14-3-3 protein interactions
- Breast Cancer Treatment Studies
- Ferroptosis and cancer prognosis
Shaanxi Provincial People's Hospital
2022-2024
Shanxi Medical University
2022-2024
Shaanxi Provincial People's Hospital
2024
Background: Energy metabolism has a complex intersection with pathogenesis and development of breast cancer (BC). This allows for the possibility identifying energy-metabolism-related genes (EMRGs) as novel prognostic biomarkers BC. 7-dehydrocholesterol reductase (DHCR7) is key enzyme cholesterol biosynthesis involved in many cancers, this paper, we investigate effects DHCR7 on proliferation mitochondrial function Methods: EMRGs were identified from Gene Expression Omnibus (GEO) MSigDB...
Objectives The coronal plane is the unique display mode of automated breast (AB) ultrasound (US), which has valuable features showing entire anatomy and providing additional diagnostic value for lesions. However, whether adding could improve performance in screening cancer remains uncertain. This study aimed to evaluate interpretation AB US screening. Methods In this retrospective study, images from 644 women (396 no‐finding group, 143 with benign lesions, 105 malignant lesions) aged 40–70...
Abstract Polysaccharopeptide (PSP) is a potential active component in traditional Chinese medicine because of its anticancer effects on variety cancer cells and as immune enhancers the system. Previous studies role PSP breast have been limited, mechanism has not clarified. This study based network pharmacology molecular docking technology to predict possible target treatment cancer, use experiments verify effect cancer. In this study, 287 targets were obtained using SwissTargetPrediction...
Abstract Background: Pertuzumab is a recombinant humanized monoclonal antibody targeting the extracellular dimerization domain II of HER2. On September 30, 2013, FDA have granted accelerated approval pertuzumab regimen for neoadjuvant treatment patients (pts) with high-risk, HER2-positive early stage breast cancer. TQB2440 (Perjeta®, Roche) biosimilar. This study aimed to compare efficacy and safety reference combined trastuzumab docetaxel in pts or locally advanced Methods: In this...
To analyze the consistency of preoperative CTLM imaging in diagnosis breast cancer lesions and postoperative pathological examination.